| |
|
|
|
|
|
Molven, Anders, Grimstvedt, Magne B., Steine, Solrun J., Harland, Mark, Avril, Marie-Françoise, Hayward, Nicholas K. and Akslen, Lars A. (2005) A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation. Genes, Chromosomes and Cancer, 44 1: 10-18.
|
45 |
|
45
|
Cited 47 times in Scopus47
|
|
Muto, Carlene A., Pokrywka, Marian, Shutt, Kathleen, Mendelsohn, Aaron B., Nouri, Kathy, Posey, Kathy, Roberts, Terri, Croyle, Karen, Krystofiak, Sharon, Patel‐Brown, Sujata, Pasculle, William, Paterson, David L., Saul, Melissa and Harrison, Lee H. (2005) A large outbreak of Clostridium difficile‐associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased Fluoroquinolone use. Infection Control and Hospital Epidemiology, 26 3: 273-280.
|
84 |
|
281
|
Cited 327 times in Scopus327
|
|
Gamboa, Dionicia, Ho, Mei-Fong, Bendezu, Jorge, Torres, Katherine, Chiodini, Peter L., Barnwell, John W., Incardona, Sandra, Perkins, Mark, Bell, David, McCarthy, James and Cheng, Qin (2010) A large proportion of P. falciparum isolates in the Amazon Region of Peru lack pfhrp2 and pfhrp3: Implications for malaria rapid diagnostic tests. PLoS One, 5 1: e8091.1-e8091.8.
|
90 |
|
53
|
Cited 57 times in Scopus57
|
|
Cust, AE, Donovan, TJ and Colditz, PB (1999) Alarm settings for the Marquette 8000 pulse oximeter to prevent hyperoxic and hypoxic episodes. Journal of Paediatrics and Child Health, 35 2: 159-162.
|
86 |
|
0
|
|
|
Jardine, L. A., Jenkins-Manning, S. and Davies, M. W. (2004) Albumin Infusion for Low Serum Albumin in Preterm Newborn Infants (Review). The Cochrane Database of Systematic Reviews 3 (CD004208).
|
766 |
655 |
|
|
|
Wang, Zhiqiang and Hoy, Wendy E. (2005) Albuminuria and Incident Coronary Heart Disease in Australian Aboriginal people. Kidney International, 68 3: 1289-1293.
|
286 |
374 |
15
|
Cited 15 times in Scopus15
|
|
Wang, Z. and Hoy, W.E. (2006). Albuminuria and the risk of developing type 2 diabetes in non-diabetic Aboriginal Australians. In: , Nephrology: Abstracts from the 42nd Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology. 42nd Annual Scientific Meeting of the Australian & New Zealand Society of Nephrology, Melbourne, Vic, Australia, (A48-A48). 14-18 August, 2006.
|
66 |
|
|
|
|
Wang, Zhiqiang and Hoy, Wendy E. (2006) Albuminuria as a marker of the risk of developing type 2 diabetes in non-diabetic Aboriginal Australians. International Journal of Epidemiology, 35 5: 1331-1335.
|
227 |
355 |
18
|
Cited 17 times in Scopus17
|
|
Kondalsamy, Chennakesavan and Hoy, W. E. (2004). Albuminuria is an early and integral component of the metabolic/vascular syndrome. In: , Nephrology: 40th Annual Scientific Meeting of the Australian & New Zealand Society of Nephrology. 40th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Adelaide Convention Centre, Adelaide, Australia, (A10-A11). 1–3 September, 2004.
|
20 |
|
|
0
|
|
Hoy, W. E. and McDonald, S. P. (2004). Albuminuria: Marker or Target in Indigenous Populations. In: Klahr, S., Kidney International: International Symposium on Albuminuria. International Symposium on Albuminuria, New York, (S25-S31). 16-18 May, 2004.
|
157 |
64 |
6
|
Cited 32 times in Scopus32
|
|
O'Keefe, James H., Bybee, Kevin A. and Lavie, Carl J. (2007) Alcohol and cardiovascular health: The razor-sharp double-edged sword. Journal of the American College of Cardiology, 50 11: 1009-1014.
|
24 |
|
119
|
Cited 135 times in Scopus135
|
|
Laliberte, Arlene and Tousignant, Michel (2009) Alcohol and other contextual factors of suicide in four aboriginal communities of Quebec, Canada. Crisis: The Journal of Crisis Intervention and Suicide Prevention, 30 4: 215-221.
|
31 |
|
5
|
Cited 7 times in Scopus7
|
|
Haber, Paul, Nakamura, Masahiko, Tsuchimoto, Kanji, Ishii, Hiromasa, Keogh, Gregory W., Apte, Minoti V., Moran, Corey S., Stewart, Nancy L., Crawford, Darrell H. G., Pirola, Romano C., McCaughan, Geoffrey W., Ramm, Grant A., Wilson, Jeremy S., Nishino, H., Kohno, M., Aizawa, R., Tajima, N., Maruyama, K., Takahashi, H., Matsushita, S., Okuyama, K., Yokoyama, A., Nakamura, Y., Shirakura, K., Conigrave, Katherine M., Hu, B. Frank, Camargo Jr, Carlos A., Stampfer, Meir J., Willett, Walter C. and Rimm, Eric B. (2001) Alcohol and the pancreas. Alcoholism-clinical And Experimental Research, 25 s1: 244S-250S.
|
163 |
|
10
|
|
|
Byrne, Gerard J. A., Raphael, Beverley and Arnold, Elizabeth (1999) Alcohol consumption and psychological distress in recently widowed older men. Australian and New Zealand Journal of Psychiatry, 33 5: 740-747.
|
127 |
|
19
|
|
|
Kune, G. A. and Vitetta, L. (1992) Alcohol consumption and the etiology of colorectal cancer: A review of the scientific evidence from 1957 to 1991. Nutrition and Cancer, 18 2: 97-111.
|
19 |
|
121
|
Cited 117 times in Scopus117
|
|
Platz, E., Rimm, E., Kawachi, I., Colditz, G. A., Stampfer, M., Willett, W.C. and Giovannucci, E. (1999) Alcohol consumption, cigarette smoking and risk of benign prostatic hyperplasia. American Journal of Epidemiology, 149 2: 106-115.
|
63 |
|
72
|
|
|
Heritage, M. L., Murphy, T. L., Popa, C., Bridle, K. R., Anderson, G. J., Crawford, D. H. G. and Fletcher, L. M. (2007). Alcohol consumption further modulates hepcidin gene expression in an animal model of hemochromatosis. In: Peter Katelaris, Journal of Gastroenterology and Hepatology. Special Issue: Australian Gastroenterology Week 2007, Perth, Australia. Australian Gastroenterology Week 2007, Perth, Australia, (A348-A348). 24–27 October 2007.
|
92 |
|
|
|
|
Fletcher, L. M., Heritage, M. L., Murphy, T. L., Popa, C., Bridle, K. R., Anderson, G. J. and Crawford, D. H. (2007). Alcohol consumption further modulates hepcidin gene expression in an animal model of hemochromatosis. In: , Hepatology. Proceedings of: The American Association for the Study of Liver Diseases. 58th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, Massachusetts, U.S.A., (884A-885A). 1-6 November 2007.
|
28 |
|
0
|
|
|
Julia D. Grant, Arpana Agrawal, Kathleen K. Bucholz, Pamela A.F. Madden, Michele L. Pergadia, Elliot C. Nelson, Michael T. Lynskey, Richard D. Todd, Alexandre A. Todorov, Narelle K. Hansell, John B. Whitfield, Nicholas G. Martin and Andrew C. Heath (2009) Alcohol consumption indices of genetic risk for alcohol dependence. Biological Psychiatry, 66 8: 795-800.
|
18 |
|
23
|
Cited 28 times in Scopus28
|
|
Garland, M., Hunter, D., Colditz, G. A., Spiegelman, D., Manson, J. E., Stampfer, M. and Willett, W. C. (1999) Alcohol consumption in relation to breast cancer risk in a cohort of United States Women 25-42 years of age. Cancer Epidemiology Biomarkers and Prevention, 8 : 873-879.
|
40 |
|
|
|
|
Feeney, GFX, Connor, JP, Young, RM, Tucker, J and McPherson, A (2004) Alcohol dependence: the impact of cognitive behaviour therapy with or without naltrexone on subjective health status. Australian And New Zealand Journal of Psychiatry, 38 10: 842-848.
|
170 |
|
12
|
Cited 12 times in Scopus12
|
|
Young, Ross McD., Connor, Jason P. and Feeney, Gerald F. X. (2011) Alcohol expectancy changes over a 12-week cognitive-behavioral therapy program are predictive of treatment success. Journal of substance Abuse Treatment, 40 1-2: 18-25.
|
39 |
|
4
|
Cited 4 times in Scopus4
|
|
Bridle, K. R., Murphy, T., Walters, M., Crawford, D. H. G. and Fletcher, L. M. (2004). Alcohol-induced down-regulation of hepcidin mRNA expression is mediated by oxidative stress. In: , Journal of Gastroenterology and Hepatology. Australian Gastroenterology Week 2004, Brisbane Convention Centre, Brisbane Qld, Australia, (A244-A244). 4-8 October, 2004.
|
16 |
|
|
|
|
Bridle, Kim, Crawford, Darrell, Fletcher, Linda, Murphy, Therese and Walters, Margaret (2004). Alcohol-induced downregulation of hepcidin mRNA expression is mediated by oxidative stress. In: , Hepatology. Proceedings of: 55th Annual Meeting of the American Association for the Study of Liver Diseases. The Liver Meeting 2004: 55th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, MA, U.S.A., (712A-712A). 29 October-2 November 2004.
|
86 |
|
|
0
|
|
White, A., Kay-Lambkin, F., Kavanagh, D., Klein, B., Proudfoot, J., Drennan, J., Connor, J., Baker, A. and Young, R. (2010). Alcohol & other drug websites: An observational and qualitative study. In: WCBCT 2010: World Congress of Behaviour and Cognitive Therapies, Boston, MA, U.S.A., (). 2-5 June, 2010.
|
42 |
|
|
|
|
Chondur R and Wang Z (2010) Alcohol use in the Northern Territory.Fact Sheet. , Department of Health and Families, NT Government.
|
16 |
|
|
|
|
Tan, T. C. H., Heritage, M., Jaskowski, L. A., Murphy, T. L., Crawford, D. H. G. and Fletcher, L. M. (2009). Alcohol withdrawal is associated with a rebound increase in hepcidin expression: further evidence for an alcohol/hepcidin interaction. In: , Abstracts of the Australia & New Zealand Medical & Surgical Gastrointestinal Week 2009. Australia & New Zealand Medical & Surgical Gastrointestinal Week 2009, Sydney, NSW, Australia, (A275-A275). 21-24 October 2009.
|
27 |
|
0
|
0
|
|
Gaddam, Krishna K., Pimenta, Eduardo, Husain, Saima and Calhoun, David A. (2009) Aldosterone and cardiovascular disease. Current Problems in Cardiology, 34 2: 51-84.
|
18 |
|
16
|
Cited 24 times in Scopus24
|
|
Gaddam, K. K., Pimenta, E., Pratt-Ubunama, M. N., Nishizaka, M. K., Aban, I., Oparil, S. and Calhoun, D. A. (2007). Aldosterone and cortisol: Is there a common stimulus in subjects with resistant hypertension?. In: , Journal of Investigative Medicine. Proceedings of: AFMR Southern Regional Meeting Abstracts. American Federation for Medical Research (AFMR) 2007 Southern Regional Meeting, New Orleans, LA, U.S.A., (S274-S274). 8-10 February 2007.
|
38 |
|
0
|
|
|
Pimenta, Eduardo and Calhoun, David A. (2009) Aldosterone and metabolic dysfunction an unresolved issue. Hypertension, 53 4: 585-586.
|
13 |
|
5
|
Cited 6 times in Scopus6
|
|
Ajani, A., Marwick, T. H. and Krum, H (2006) Aldosterone antagonists: a new treatment option for patients with post-myocardial infarction heart failure. Cardiovascular Revascularization Medicine, 7 4: 234-236.
|
37 |
|
|
Cited 2 times in Scopus2
|
|
Phelan, D., Thavendiranathan, P., Collier, P. and Marwick, T.H. (2012) Aldosterone antagonists improve ejection fraction and functional capacity independently of functional class: A meta-analysis of randomised controlled trials. Heart, 98 3: 1693-1700-1693-1700.
|
26 |
|
|
Cited 1 times in Scopus1
|
|
Stowasser, Michael and Gordon, Richard D. (2006) Aldosterone assays: An urgent need for improvement. Clinical Chemistry, 52 9: 1640-1642.
|
21 |
|
15
|
Cited 13 times in Scopus13
|
|
Pimenta, Eduardo and Calhoun, David A. (2006) Aldosterone, dietary salt, and renal disease hypertension. Hypertension, 48 2: 209-210.
|
29 |
|
11
|
Cited 12 times in Scopus12
|
|
Pimenta, Eduardo, Gaddam, Krishna K., Pratt-Ubunama, Monique N., Nishizaka, Mari K., Cofield, Stacey S., Oparil, Suzanne and Calhoun, David A. (2007) Aldosterone excess and resistance to 24-h blood pressure control. Journal of Hypertension, 25 10: 2131-2137.
|
31 |
|
15
|
Cited 20 times in Scopus20
|
|
Stowasser, Michael and Gordon, Richard D. (2007) Aldosterone excess, hypertension, and chromosome 7p22: Evidence continues to mount. Hypertension, 49 4: 761-762.
|
33 |
|
1
|
Cited 1 times in Scopus1
|
|
Gaddam, Krishna K., Corros, Cecilia, Pimenta, Eduardo, Husain, Saima, Gupta, Himanshu, Lloyd, Steven G., Oparil, Suzanne, Husain, Ahsan, Dell'Italia, Louis J. and Calhoun, David A. (2008). Aldosterone excess increases left and right heart volumes in patients with resistant hypertension: Spironolactone but not thiazide diuretics overcome it. In: , Abstracts of the American Society of Hypertension 23rd Annual Scientific Meeting. American Society of Hypertension (ASH) 23nd Annual Scientific Meeting and Exposition, New Orleans, LA, United States, (P-219-P-219). 14-17 May 2008.
|
122 |
|
|
0
|
|
Stowasser, M. and Gordon, R. (2004) Aldosterone excess in hypertension - Reply. Journal of Hypertension, 22 4: 861-862.
|
57 |
|
0
|
0
|
|
Pimenta, E., Pratt-Ubunama, M. N., Gaddam, K. K., Nishizaka, M. K., Oparil, S. and Calhoun, D. A. (2007). Aldosterone excess is associated with true treatment resistance as indicated by sustained ambulatory blood pressure levels and less white-coat effect. In: , Journal of Investigative Medicine. 8th Conference of the Western Student Medical Research Forum, Monterey, U.S., (S276-S276). 2 February, 2007.
|
33 |
|
0
|
|
|
Ubaid-Girioli, Samira, de Souza, Leoní Adriana, Yugar-Toledo, Juan Carlos, Martins, Luiz Cláudio, Ferreira-Melo, Sílvia, Coelho, Otávio Rizzi, Sierra, Cristina, Coca, Antonio, Pimenta, Eduardo and Moreno, Heitor (2009) Aldosterone excess or escape: Treating resistant hypertension. The Journal of Clinical Hypertension, 11 5: 245-252.
|
65 |
|
9
|
Cited 11 times in Scopus11
|
|
Gaddam, K. K., Corros, C., Pimenta, E., Husain, S., Husain, A., Gupta, H., Lloyd, S. G., Oparil, S., Dell'Italia, L. J. and Calhoun, D. A. (2008). Aldosterone induces intracardiac volume overload in patients with resistant hypertension - spironolactone but not thiazide diuretics overcomes it. In: , Journal of Investigative Medicine. 2008 AFMR Southern Regional Meeting, New Orleans, USA, (433-433). 21-23 February 2008.
|
80 |
|
0
|
|
|
Nash, P. (2006) Alefacept plus methotrexate for psoriatic arthritis. Nature Clinical Practice: Rheumatology, 2 9: 470-471.
|
286 |
|
3
|
Cited 5 times in Scopus5
|
|
Coles, Alasdair J., Twyman, Cary L., Arnold, Douglas L., Cohen, Jeffrey A., Confavreux, Christian, Fox, Edward J., Hartung, Hans-Peter, Havrdova, Eva, Selmaj, Krzysztof W., Weiner, Howard L., Miller, Tamara, Fisher, Elizabeth, Sandbrink, Rupert, Lake, Stephen L., Margolin, David H., Oyuela, Pedro, Panzara, Michael A., Compston, D. Alastair S., CARE-MS II investigators and McCombe, Pamela Ann (2012) Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial. Lancet, 380 9856: 1829-1839.
|
44 |
3 |
9
|
Cited 12 times in Scopus12
|
|
Cohen, Jeffrey A., Coles, Alasdair J., Arnold, Douglas L., Confavreux, Christian, Fox, Edward J., Hartung, Hans-Peter, Havrdova, Eva, Selmaj, Krzysztof W., Weiner, Howard L., Fisher, Elizabeth, Brinar, Vesna V., Giovannoni, Gavin, Stojanovic, Miroslav, Ertik, Bella I., Lake, Stephen L., Margolin, David H., Panzara, Michael A., Compston, D. Alastair S., CARE-MS I investigators and McCombe, Pamela (2012) Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial. Lancet, 380 9856: 1819-1828.
|
28 |
3 |
10
|
Cited 11 times in Scopus11
|
|
Miflin, B. M., Campbell, C. B. and Price, D. A. (1999) A lesson from the introduction of a problem-based, graduate entry course: the effects of different views of self-direction. Medical Education, 33 11: 801-807.
|
47 |
|
36
|
|
|
Arumugam, Deepak, Atherton, John J. and Martin, Paul T. (2012) A lethal injection?. Lancet, 379 9814: 492-492.
|
14 |
|
1
|
0
|
|
Thorberg, Fred Arne, Young, R. M., Sullivan, K. A., Lyvers, M., Connor, J. P., Landheim, A. S., Tyssen, R. and Feeney, G. F. X. (2012). Alexithymia in alcohol dependent patients: Gender differences, associations with craving and dependence severity. In: , Special Issue: XXX International Congress of Psychology. 30th International Congress of Psychology, Cape Town, South Africa, (94-94). 22-27 July 1012.
|
8 |
|
0
|
|
|
Thorberg, Fred Arne, Young, Ross McD., Sullivan, Karen A., Lyvers, Michael, Hurst, Cameron P., Connor, Jason P. and Feeney, Gerald F. X. (2011) Alexithymia in alcohol dependent patients is partially mediated by alcohol expectancy. Drug and Alcohol Dependence, 116 1-3: 238-241.
|
45 |
|
5
|
Cited 5 times in Scopus5
|
|
Eadie, M. J. (2003) Alfred Walter Campbell (1868-1937). Journal of Neurology, 250 2: 249-250.
|
30 |
|
1
|
Cited 1 times in Scopus1
|
|
Darnton-Hill, I., Nishida, C. and James, W.P.T. (2004) A life course approach to diet, nutrition and the prevention of chronic disease. Public Health Nutrition, 7 Special Issue 1: 101-121.
|
73 |
|
60
|
Cited 66 times in Scopus66
|
